SAT0220 Effects of Type I Interferon Inhibition on Blood Leukocyte Subsets in Patients Treated in a Phase IIB Clinical Study of Anifrolumab in Systemic Lupus Erythematosus (SLE)

doi 10.1136/annrheumdis-2017-eular.3833
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Type I Interferon and Systemic Lupus Erythematosus

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Malignancy in Systemic Lupus Erythematosus (SLE) Patients

Asian Pacific Journal of Cancer Prevention
2018English

Clinical Picture of Lupus Nephritis in Patients With Systemic Lupus Erythematosus (SLE): Results of a Large Survey

Rheumatology Research
2017English

Systemic Lupus Erythematosus (SLE)

English

Systemic Lupus Erythematosus (SLE)

English

402 Clinical Picture of Lupus Nephritis in Persian Patients With Systemic Lupus Erythematosus (Sle): Results of a Large Survey

2017English

Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus

ACR Open Rheumatology
2019English

Interferon Alpha in Systemic Lupus Erythematosus

Journal of Biomedicine and Biotechnology
2010English

T-Helper 17 Cell Cytokines and Interferon Type I: Partners in Crime in Systemic Lupus Erythematosus?

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy